Fierce Pharma

Amid the Trump administration’s call for a crackdown on direct-to-consumer [...]

A federal judge granted Gilead summary judgment in a lawsuit [...]

A week after rejecting an appeal from BMS and J&J [...]

In the current climate, there is an urgent need for [...]

The highly debatable HARMONi data, along with the trial design [...]

In a keynote session Tuesday at the Fierce Pharma Week [...]

Lundbeck is making a big push on the company’s capital [...]

By nailing the primary endpoint in a phase 3 trial, [...]

Industry watchers who cheered on Summit Therapeutics’ claim that the [...]

Five months after embarking on a “massive testing and research [...]